| |
Symbol |
Name |
Market Cap |
Exchange |
Z-Score |
 | XLRN  | Acceleron Pharma Inc | $1.1B | NASDAQ | 29.0909 |
| ACRX | AcelRx Pharmaceuticals Inc | $113.3M | NASDAQ | -1.5052 |
| AKAO | Achaogen Inc | $815.5M | NASDAQ | 7.1453 |
| ACHN | Achillion Pharmaceuticals, Inc. | $529.0M | NASDAQ | 22.5575 |
| ACRS | Aclaris Therapeutics Inc | $572.1M | NASDAQ | 58.3345 |
| ACOR | Acorda Therapeutics Inc | $732.6M | NASDAQ | 1.1994 |
| ATNM | Actinium Pharmaceuticals Inc | $78.0M | NYSE MKT | 3.049 |
| ADAP | Adaptimmune Therapeutics PLC - ADR | $278.1M | NASDAQ | 7.7877 |
| ADMA | ADMA Biologics Inc | $55.9M | NASDAQ | -4.111 |
| ADRO | Aduro BioTech Inc | $641.0M | NASDAQ | 2.4835 |
| ADVM | Adverum Biotechnologies Inc | $126.1M | NASDAQ | 4.7025 |
| AGLE | Aeglea Bio Therapeutics Inc | $84.5M | NASDAQ | 14.8602 |
| AERI | Aerie Pharmaceuticals Inc | $1.3B | NASDAQ | 6.0036 |
| AFMD | Affimed NV | $73.2M | NASDAQ | 6.7708 |
| AGRX | Agile Therapeutics Inc | $100.9M | NASDAQ | -1.1068 |
| AGIO | Agios Pharmaceuticals Inc | $2.0B | NASDAQ | 4.1239 |
| AKTX | Akari Therapeutics PLC (ADR) | $111.1M | NASDAQ | 7.983 |
| AKBA | Akebia Therapeutics Inc | $493.1M | NASDAQ | 0.2589 |
| BIOD | Albireo Pharma Inc | $41.7M | NASDAQ | -1.3011 |
| ADHD | Alcobra Ltd | $32.2M | NASDAQ | 2.878 |
| ALDR | Alder Biopharmaceuticals Inc | $913.3M | NASDAQ | 26.7271 |
| ALDX | Aldeyra Therapeutics Inc | $49.2M | NASDAQ | 6.0897 |
| AMRN | Amarin Corporation plc (ADR) | $553.0M | NASDAQ | -6.8407 |
| AMGN | Amgen, Inc. | $118.0B | NASDAQ | 2.4006 |
| AMPE | Ampio Pharmaceuticals Inc | $46.2M | NYSE MKT | -11.4887 |
| ANTH | Anthera Pharmaceuticals Inc | $21.4M | NASDAQ | -21.8026 |
| AGTC | Applied Genetic Technologies Corp | $104.8M | NASDAQ | 1.2366 |
| APVO | Aptevo Therapeutics Inc | $41.9M | NASDAQ | 0.4018 |
| ARDM | Aradigm Corporation | $13.4M | NASDAQ | -23.0242 |
| ARDX | Ardelyx Inc | $353.1M | NASDAQ | 18.7908 |
| ARIA | Ariad Pharmaceuticals, Inc. | $4.7B | NASDAQ | -1.291 |
| ARRY | Array Biopharma Inc | $949.8M | NASDAQ | -3.6314 |
| ARWR | Arrowhead Pharmaceuticals Inc | $126.8M | NASDAQ | -2.0507 |
| ASND | Ascendis Pharma A/S | $508.9M | NASDAQ | 20.111 |
| ATRA | Atara Biotherapeutics Inc | $439.4M | NASDAQ | 34.2465 |
| ATHX | Athersys, Inc. | $166.9M | NASDAQ | -12.3547 |
| BOLD | Audentes Therapeutics Inc | $374.4M | NASDAQ | 12.2021 |
| AUPH | Aurinia Pharmaceuticals Inc | $602.5M | NASDAQ | |
| EARS | Auris Medical Holding AG | $24.1M | NASDAQ | -2.7241 |
| AVEO | AVEO Pharmaceuticals, Inc. | $43.2M | NASDAQ | -25.0621 |
| AVXS | AveXis Inc | $1.8B | NASDAQ | 42.6926 |
| AVIR | Aviragen Therapeutics Inc | $19.3M | NASDAQ | 0.0358 |
| AXSM | Axsome Therapeutics Inc | $79.5M | NASDAQ | 2.8133 |
| BGNE | Beigene Ltd (ADR) | $1.2B | NASDAQ | 13.9383 |
| BLPH | Bellerophon Therapeutics Inc | $51.8M | NASDAQ | -2.7278 |
| BLCM | Bellicum Pharmaceuticals Inc | $343.0M | NASDAQ | 7.4987 |
| ORPN | Bio Blast Pharma Ltd | $7.1M | NASDAQ | -0.0027 |
| BCRX | BioCryst Pharmaceuticals, Inc. | $431.1M | NASDAQ | -4.5137 |
| BPMX | Biopharmx Corp | $31.4M | NYSE MKT | 8.4076 |
| APPY | Bioptix Inc | $17.7M | NASDAQ | -4.7044 |
| BSTC | BioSpecifics Technologies Corp. | $393.8M | NASDAQ | 27.4249 |
| BSPM | Biostar Pharmaceuticals Inc | $4.7M | NASDAQ | 0.764 |
| BTX | BioTime, Inc. | $329.8M | NYSE MKT | 6.2858 |
| BLUE | bluebird bio Inc | $3.3B | NASDAQ | 7.3333 |
| CALA | Calithera Biosciences Inc | $385.3M | NASDAQ | 34.0968 |
| CAPR | Capricor Therapeutics Inc | $24.8M | NASDAQ | -1.6106 |
| CASC | Cascadian Therapeutics Inc (USA) | $83.5M | NASDAQ | -3.4793 |
| CATB | Catabasis Pharmaceuticals Inc | $30.3M | NASDAQ | -2.4531 |
| CPRX | Catalyst Pharmaceuticals Inc | $161.6M | NASDAQ | 32.7198 |
| CVM | CEL-SCI Corporation | $23.8M | NYSE MKT | -33.5344 |
| CELG | Celgene Corporation | $92.5B | NASDAQ | 3.8583 |
| CBMG | Cellular Biomedicine Group Inc | $75.7M | NASDAQ | 34.1056 |
| CLSN | Celsion Corporation | $13.3M | NASDAQ | -10.7038 |
| CEMP | Cempra Inc | $1.3B | NASDAQ | 14.9979 |
| CERU | Cerulean Pharma Inc | $13.1M | NASDAQ | -6.3346 |
| CMRX | Chimerix Inc | $214.4M | NASDAQ | 15.4674 |
| CBPO | China Biologic Products Inc | $3.0B | NASDAQ | 13.5453 |
| CDTX | Cidara Therapeutics Inc | $122.6M | NASDAQ | 4.0432 |
| CLSD | Clearside Biomedical Inc | $184.7M | NASDAQ | 7.4973 |
| CLVS | Clovis Oncology Inc | $1.8B | NASDAQ | 0.261 |
| CHRS | Coherus Biosciences Inc | $969.5M | NASDAQ | 1.3776 |
| CNAT | Conatus Pharmaceuticals Inc | $114.0M | NASDAQ | -0.7108 |
| CTRV | ContraVir Pharmaceuticals Inc | $45.3M | NASDAQ | -2.7519 |
| CRBP | Corbus Pharmaceuticals Holdings Inc | $280.0M | NASDAQ | 26.6079 |
| CYCCP | Cyclacel Pharmaceuticals Inc | $21.8M | NASDAQ | 3.3066 |
| CYCC | Cyclacel Pharmaceuticals Inc | $22.9M | NASDAQ | 2.6598 |
| CBAY | CymaBay Therapeutics Inc | $92.4M | NASDAQ | -26.7117 |
| CYNA | Cynapsus Therapeutics Inc | $504.0M | NASDAQ | |
| CYTK | Cytokinetics, Inc. | $571.7M | NASDAQ | 4.7096 |
| CTMX | CytomX Therapeutics Inc | $530.5M | NASDAQ | 2.4926 |
| DERM | Dermira Inc | $952.4M | NASDAQ | 12.1402 |
| DMTX | Dimension Therapeutics Inc | $31.3M | NASDAQ | 0.2063 |
| DPRX | Dipexium Pharmaceuticals Inc | $13.9M | NASDAQ | 0.3519 |
| DRRX | DURECT Corporation | $167.7M | NASDAQ | -12.3275 |
| DVAX | Dynavax Technologies Corporation | $259.1M | NASDAQ | -2.0352 |
| EDGE | Edge Therapeutics Inc | $302.0M | NASDAQ | 6.9849 |
| EGLT | Egalet Corp | $76.4M | NASDAQ | -1.2306 |
| EBIO | Eleven Biotherapeutics Inc | $34.1M | NASDAQ | -0.7155 |
| ECYT | Endocyte, Inc. | $122.5M | NASDAQ | 8.3951 |
| EPZM | Epizyme Inc | $947.6M | NASDAQ | 10.9035 |
| EXEL | Exelixis, Inc. | $5.0B | NASDAQ | 2.3489 |
| FATE | Fate Therapeutics Inc | $136.9M | NASDAQ | 2.9069 |
| FPRX | Five Prime Therapeutics Inc | $845.4M | NASDAQ | 13.8007 |
| FLKS | Flex Pharma Inc | $62.7M | NASDAQ | 11.2072 |
| FLXN | Flexion Therapeutics Inc | $613.3M | NASDAQ | 12.9415 |
| FOMX | Foamix Pharmaceuticals Ltd | $176.8M | NASDAQ | 32.5151 |
| FWP | Forward Pharma A/S | $820.2M | NASDAQ | 95.8399 |
| GLMD | Galmed Pharmaceuticals Ltd | $53.7M | NASDAQ | 1.42 |
| GEMP | Gemphire Therapeutics Inc | $92.6M | NASDAQ | 12.3594 |
| GERN | Geron Corporation | $456.7M | NASDAQ | 17.3178 |
| GILD | Gilead Sciences, Inc. | $86.5B | NASDAQ | 2.5416 |
| GLYC | GlycoMimetics Inc | $115.3M | NASDAQ | 9.6837 |
| GWPH | GW Pharmaceuticals PLC- ADR | $2.7B | NASDAQ | 26.0052 |
| HALO | Halozyme Therapeutics, Inc. | $1.8B | NASDAQ | 1.9375 |
| HTBX | Heat Biologics Inc | $19.1M | NASDAQ | 114.429 |
| HEB | Hemispherx BioPharma, Inc | $15.2M | NYSE MKT | -19.6925 |
| RXDX | Ignyta Inc | $277.0M | NASDAQ | 2.96 |
| IMDZ | Immune Design Corp | $125.1M | NASDAQ | 2.8413 |
| IMMY | Imprimis Pharmaceuticals Inc | $49.5M | NASDAQ | -1.4264 |
| ITEK | Inotek Pharmaceuticals Corp | $44.4M | NASDAQ | -0.8861 |
| INSM | Insmed Incorporated | $1.1B | NASDAQ | 3.5008 |
| INSY | Insys Therapeutics Inc | $835.6M | NASDAQ | 6.3789 |
| NTEC | Intec Pharma Ltd | $59.2M | NASDAQ | |
| ICPT | Intercept Pharmaceuticals Inc | $2.9B | NASDAQ | 3.3979 |
| ITCI | Intra-Cellular Therapies Inc | $488.9M | NASDAQ | 27.7963 |
| JUNO | Juno Therapeutics Inc | $2.6B | NASDAQ | 4.8317 |
| KPTI | Karyopharm Therapeutics Inc | $350.5M | NASDAQ | 10.2698 |
| KMPH | KemPharm Inc | $61.5M | NASDAQ | -0.6917 |
| KERX | Keryx Biopharmaceuticals | $692.6M | NASDAQ | -5.0524 |
| KIN | Kindred Biosciences Inc | $139.2M | NASDAQ | 17.7241 |
| KITE | Kite Pharma Inc | $3.7B | NASDAQ | 22.1616 |
| KTOV | Kitov Pharmaceuticals Holdings Ltd (ADR) | $13.2M | NASDAQ | |
| KURA | Kura Oncology Inc | $192.5M | NASDAQ | 8.7755 |
| LJPC | La Jolla Pharmaceutical Company | $626.6M | NASDAQ | 27.7499 |
| LXRX | Lexicon Pharmaceuticals, Inc. | $1.7B | NASDAQ | 0.0886 |
| LPCN | Lipocine Inc | $66.6M | NASDAQ | 32.8068 |
| LOXO | Loxo Oncology Inc | $938.7M | NASDAQ | 36.8295 |
| MGNX | MacroGenics Inc | $672.4M | NASDAQ | 9.9404 |
| MDGL | Madrigal Pharmaceuticals Inc | $180.3M | NASDAQ | 20.8068 |
| MNKD | MannKind Corporation | $99.4M | NASDAQ | -33.9723 |
| MNOV | MediciNova, Inc. | $188.9M | NASDAQ | 13.013 |
| MDVN | Medivation Inc | $13.5B | NASDAQ | 12.903 |
| MEIP | MEI Pharma Inc | $56.0M | NASDAQ | 2.4896 |
| MRUS | Merus NV | $293.6M | NASDAQ | 3.2226 |
| STEM | Microbot Medical Inc | $34.9M | NASDAQ | 13.3709 |
| MTP | Midatech Pharma PLC-ADR | $45.8M | NASDAQ | |
| NERV | Minerva Neurosciences Inc | $261.1M | NASDAQ | 5.158 |
| MYOK | Myokardia Inc | $378.3M | NASDAQ | 4.7542 |
| NBRV | Nabriva Therapeutics AG - ADR | $20.5M | NASDAQ | 3.0281 |
| NNVC | NanoViricides Inc | $70.7M | NYSE MKT | 2.2466 |
| NK | Nantkwest Inc | $327.6M | NASDAQ | 5.9739 |
| NBIX | Neurocrine Biosciences, Inc. | $4.7B | NASDAQ | 42.5746 |
| NDRM | Neuroderm Ltd | $512.0M | NASDAQ | 51.9667 |
| NVET | Nexvet Biopharma plc | $78.8M | NASDAQ | 4.2072 |
| NVLS | Nivalis Therapeutics Inc | $37.3M | NASDAQ | 0.766 |
| NVCR | Novocure Ltd | $1.0B | NASDAQ | 1.2086 |
| OMER | Omeros Corporation | $574.5M | NASDAQ | -5.8199 |
| OCX | OncoCyte Corp | $148.8M | NYSE MKT | 16.7674 |
| OPXA | Opexa Therapeutics Inc | $4.1M | NASDAQ | -54.2446 |
| OPHT | Ophthotech Corp | $91.0M | NASDAQ | -1.511 |
| OREX | Orexigen Therapeutics, Inc. | $48.3M | NASDAQ | -2.1327 |
| OTIC | Otonomy Inc | $432.9M | NASDAQ | 14.2439 |
| PTIE | Pain Therapeutics, Inc. | $29.6M | NASDAQ | 14.1336 |
| PRTK | Paratek Pharmaceuticals Inc | $519.4M | NASDAQ | 0.5467 |
| PFNX | Pfenex Inc | $108.8M | NYSE MKT | 2.9622 |
| PIP | PharmAthene, Inc. | $44.7M | NYSE MKT | 0.0869 |
| PZRX | PhaseRx Inc | $14.5M | NASDAQ | -3.5955 |
| PIRS | Pieris Pharmaceuticals Inc | $163.6M | NASDAQ | 3.0137 |
| PGNX | Progenics Pharmaceuticals, Inc. | $502.5M | NASDAQ | 2.6491 |
| DNAI | ProNAi Therapeutics Inc | $41.9M | NASDAQ | -2.9808 |
| PRQR | ProQR Therapeutics NV | $119.1M | NASDAQ | 5.8256 |
| PRTO | Proteon Therapeutics Inc | $24.1M | NASDAQ | -0.6723 |
| PTI | Proteostasis Therapeutics Inc | $112.2M | NASDAQ | 9.3681 |
| PRTA | Prothena Corporation PLC | $1.9B | NASDAQ | 12.9503 |
| PSDV | pSivida Corp. | $71.1M | NASDAQ | -5.1667 |
| PTCT | PTC Therapeutics, Inc. | $218.8M | NASDAQ | 0.0452 |
| PULM | Pulmatrix Inc | $47.9M | NASDAQ | -8.3222 |
| RDUS | Radius Health Inc | $1.5B | NASDAQ | 31.2381 |
| RPTP | Raptor Pharmaceutical Corp. | $767.8M | NASDAQ | 0.6981 |
| RETA | Reata Pharmaceuticals Inc | $168.8M | NASDAQ | -3.1971 |
| REPH | Recro Pharma Inc | $78.1M | NASDAQ | 0.7724 |
| REGN | Regeneron Pharmaceuticals Inc | $45.7B | NASDAQ | 9.9971 |
| RGNX | Regenxbio Inc | $489.7M | NASDAQ | 28.2202 |
| RLYP | Relypsa Inc | $1.4B | NASDAQ | 7.6424 |
| RTRX | Retrophin Inc | $648.6M | NASDAQ | 2.6482 |
| RVNC | Revance Therapeutics Inc | $573.9M | NASDAQ | 10.2146 |
| RNN | Rexahn Pharmaceuticals, Inc. | $108.3M | NYSE MKT | 1.9979 |
| RIGL | Rigel Pharmaceuticals, Inc. | $265.1M | NASDAQ | -11.0436 |
| RTTR | Ritter Pharmaceuticals Inc | $5.3M | NASDAQ | -5.1429 |
| SGMO | Sangamo Therapeutics Inc | $589.9M | NASDAQ | 6.5227 |
| SRPT | Sarepta Therapeutics Inc | $1.9B | NASDAQ | 9.8924 |
| MSTX | Savara Inc | $33.1M | NYSE MKT | -21.7447 |
| SELB | Selecta Biosciences Inc | $245.7M | NASDAQ | 3.1259 |
| MCRB | Seres Therapeutics Inc | $403.1M | NASDAQ | 1.7972 |
| SRNE | Sorrento Therapeutics Inc | $86.5M | NASDAQ | -0.1225 |
| ONCE | Spark Therapeutics Inc | $1.8B | NASDAQ | 24.7571 |
| SBPH | Spring Bank Pharmaceuticals Inc | $86.8M | NASDAQ | 2.2332 |
| STDY | Steadymed Ltd | $141.5M | NASDAQ | 2.611 |
| STML | Stemline Therapeutics Inc | $206.7M | NASDAQ | 10.0875 |
| SCMP | Sucampo Pharmaceuticals, Inc. | $497.2M | NASDAQ | 1.9893 |
| SMMT | Summit Therapeutics PLC (ADR) | $134.1M | NASDAQ | |
| SGYP | Synergy Pharmaceuticals Inc | $777.0M | NASDAQ | 3.4429 |
| SYN | Synthetic Biologics Inc | $60.6M | NYSE MKT | -7.7179 |
| TSRO | TESARO Inc | $7.5B | NASDAQ | 23.8353 |
| TBRA | Tobira Therapeutics Inc | $462.0M | NASDAQ | -1.1323 |
| TCON | TRACON Pharmaceuticals Inc | $41.5M | NASDAQ | 0.1088 |
| TRVN | Trevena Inc | $184.5M | NASDAQ | 0.9872 |
| RARE | Ultragenyx Pharmaceutical Inc | $2.3B | NASDAQ | 26.8898 |
| QURE | Uniqure NV | $123.8M | NASDAQ | -1.3394 |
| VNDA | Vanda Pharmaceuticals Inc. | $627.6M | NASDAQ | 4.0202 |
| VBLT | Vascular Biogenics Ltd | $165.4M | NASDAQ | 15.3581 |
| VSTM | Verastem Inc | $90.6M | NASDAQ | 1.1239 |
| VSAR | Versartis Inc | $517.0M | NASDAQ | 8.1082 |
| VRTX | Vertex Pharmaceuticals Incorporated | $28.4B | NASDAQ | 9.4259 |
| VICL | Vical Incorporated | $25.0M | NASDAQ | -7.8404 |
| VTL | Vital Therapies Inc | $97.8M | NASDAQ | 10.4697 |
| VTVT | vTv Therapeutics Inc | $171.6M | NASDAQ | -3.8426 |
| XBIT | XBiotech Inc | $313.7M | NASDAQ | 42.9047 |
| XNCR | Xencor Inc | $913.6M | NASDAQ | 5.1255 |
| XENE | Xenon Pharmaceuticals Inc | $75.6M | NASDAQ | 12.1138 |
| XOMA | XOMA Corp | $37.7M | NASDAQ | -19.2268 |
| ZFGN | Zafgen Inc | $112.9M | NASDAQ | 5.9543 |
| ZIOP | ZIOPHARM Oncology Inc. | $969.5M | NASDAQ | 0.6725 |
| ZSAN | Zosano Pharma Corp | $47.7M | NASDAQ | -11.7598 |
= link to the company website, 
